These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26442580)

  • 41. Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality.
    Lin S; Wang Z; Xing M
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1222-1230. PubMed ID: 38064679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of re-excision for positive and close resection margins in patients treated with breast-conserving surgery.
    Biglia N; Ponzone R; Bounous VE; Mariani LL; Maggiorotto F; Benevelli C; Liberale V; Ottino MC; Sismondi P
    Breast; 2014 Dec; 23(6):870-5. PubMed ID: 25305040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased expression of thyroid hormone receptor alpha and estrogen receptor alpha in breast cancer associated with thyroid cancer.
    Kim YA; Kim YA; Cho SW; Song YS; Min HS; Park IA; Park DJ; Hwang KT; Park YJ
    Eur J Surg Oncol; 2021 Jun; 47(6):1316-1323. PubMed ID: 33558123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    Cheng Y; Huang Z; Liao Q; Yu X; Jiang H; He Y; Yao S; Nie S; Liu L
    PLoS One; 2020; 15(6):e0232800. PubMed ID: 32497148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
    Cheng W; Shen X; Xing M
    PLoS One; 2019; 14(10):e0221093. PubMed ID: 31644578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of manganese superoxide dismutase in patients with breast cancer.
    Tsai SM; Hou MF; Wu SH; Hu BW; Yang SF; Chen WT; Chai CY; Ma H; Tsai LY
    Kaohsiung J Med Sci; 2011 May; 27(5):167-72. PubMed ID: 21527182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province.
    Jiang Y; Han J; Liu J; Zhang G; Wang L; Liu F; Zhang X; Zhao Y; Pang D
    Breast Cancer Res Treat; 2011 Jul; 128(1):251-7. PubMed ID: 21197568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast conservative surgery for well-differentiated ductal intraepithelial neoplasia: Risk factors for ipsilateral breast tumor recurrence.
    Toesca A; Botteri E; Lazzeroni M; Vila J; Manika A; Ballardini B; Bettarini F; Guerrieri-Gonzaga A; Bonanni B; Rotmensz N; Viale G; Veronesi P; Luini A; Veronesi U; Gentilini O
    Breast; 2014 Dec; 23(6):829-35. PubMed ID: 25261930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinicopathologic analysis of the nipple-areolar complex occult involvement in early stage breast carcinoma].
    Wang SY; Peng DF; Cai ZG; Zhang RZ; Yao TJ; Zhang H; Yang M; Dong HM
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):203-6. PubMed ID: 18756937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation.
    Hill-Kayser CE; Harris EE; Hwang WT; Solin LJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1313-9. PubMed ID: 16997501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laterality of breast cancer at Dr George Mukhari Academic Hospital.
    Mokone-Fatunla DH; Koto MZ; Becker JHR; Bondo M; Mundawarara S
    S Afr J Surg; 2019 Sep; 57(3):56. PubMed ID: 31392868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence of an anatomically separate carcinoma of the breast in patients diagnosed with a papillary lesion on breast core biopsy.
    Chung M; Koenigsberg T; Shapiro N; Fineberg S
    Breast J; 2015; 21(2):200-2. PubMed ID: 25583456
    [No Abstract]   [Full Text] [Related]  

  • 54. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
    Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay.
    Barcenas CH; Raghavendra A; Sinha AK; Syed MP; Hsu L; Patangan MG; Chavez-MacGregor M; Shen Y; Hortobagyi GH; Valero V; Giordano SH; Ueno NT; Tripathy D
    Cancer; 2017 Jul; 123(13):2422-2431. PubMed ID: 28199747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
    Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
    Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from Trentino, North East Italy.
    Giuliani S; Leonardi E; Aldovini D; Bernardi D; Pellegrini M; Soli F; Ferro A; Dalla Palma P; Decarli N; Barbareschi M
    Pathologica; 2012 Jun; 104(3):93-7. PubMed ID: 22931039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicopathological significance of CADM4 expression in invasive ductal carcinoma of the breast.
    Jang SM; Sim J; Han H; Ahn HI; Kim H; Yi K; Jun YJ; Rehman A; Chung MS; Jang K; Paik SS
    J Clin Pathol; 2013 Aug; 66(8):681-6. PubMed ID: 23559354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Breast cancer in female survivors of Wilms tumor: a report from the national Wilms tumor late effects study.
    Lange JM; Takashima JR; Peterson SM; Kalapurakal JA; Green DM; Breslow NE
    Cancer; 2014 Dec; 120(23):3722-30. PubMed ID: 25348097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.